Trane 10-Q: Q3 EPS $4.74 as Gross Margin Slips 160 bps; Asbestos Estimate Set at $742.5M
TT sits 23% above its 52-week low of $348.06.
Summary
Trane's Q3 10-Q shows 17.7% revenue growth to $6.8B and $4.74 diluted EPS, but gross margin fell 160 bps and EMEA/Asia margins compressed sharply. Nine-month free cash flow nearly doubled to $2.8B, funding heavy buybacks.
Key Events · Earnings and Guidance · TT
-
Q3 Revenue Up 17.7%, EPS $4.74
Net revenues of $6,759.7 million versus $5,742.5 million, with operating income of $1,343.1 million and diluted EPS of $4.74 (continuing operations $4.79).
-
Gross Margin Down 160 bps
Gross margin fell to 35.3% from 36.9% on inflation and investments, only partly offset by productivity and price; Americas adjusted EBITDA margin rose 40 bps to 23.5% while EMEA fell 230 bps to 18.7% and Asia Pacific 360 bps to 19.7%.
-
Free Cash Flow Nearly Doubles
Nine-month free cash flow was $2,827.5 million versus $1,786.0 million, supporting $1,338.5 million of buybacks and $693.7 million of dividends.
-
Asbestos Estimate Set at $742.5M
The Bankruptcy Court issued a non-binding September 25, 2026 order estimating tort system value of Aldrich and Murray asbestos liabilities at $742.5 million — above the $545.0 million plan funding but not an accrued liability; the Chapter 11 cases remain pending.
Analysis · TT · Industrial Applications And Services
The headline numbers were already out this morning, but the 10-Q is where the quality of the quarter shows. Revenue rose 17.7% to $6,759.7 million and operating income grew to $1,343.1 million, yet gross margin fell 160 basis points to 35.3% on inflation and investments — growth is being bought with margin. The mix is lopsided: Americas adjusted EBITDA margin improved 40 basis points to 23.5% while EMEA fell 230 basis points to 18.7% and Asia Pacific fell 360 basis points to 19.7%, so the international recovery is not happening yet. Cash generation is the strongest part of the story, with nine-month free cash flow of $2,827.5 million versus $1,786.0 million a year ago, funding $1,338.5 million of buybacks and $693.7 million of dividends. Two items deserve attention: the Bankruptcy Court's September 25, 2026 non-binding estimate of $742.5 million for Aldrich/Murray asbestos liabilities (above the $545.0 million plan funding, though explicitly not an accrued liability), and a fresh round of 10b5-1 selling plans adopted by the CEO, CFO, CAO and CHRO during the quarter.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TT was trading at $429.07 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $94.4B. The 52-week trading range was $348.06 to $505.87. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.